The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 27 | — | 20.1x | Below average | |
Growth | 10 | -53.3% | 5.6% | Below average | |
Quality | 69 | 3.3% | 7.6% | Above average | |
Safety | 22 | 88.2x | 0.4x | Below average | |
Capital Return | 95 | — | 2.19% | Above average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
PTC Therapeutics, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy PTC Therapeutics, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
PTCT stock saw stability in its average price target at $95.83 over the past week, following a slight decline of 2.21% compared to the previous month's levels ($98). Despite this minor downward adjustment in consensus, recent ratings reflect growing optimism; major institutions such as Jefferies and TD Cowen have upgraded their recommendations to 'Buy', indicating confidence in the company's operational trajectory despite varying historical profitability estimates.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.